Development of the multiple metabolic syndrome: An epidemiologic perspective

Epidemiologic Reviews

Volumn 20, Issue 2, 1998, Pages 157-172

  Liese, Angela D ^a   Mayer Davis, Elizabeth J ^b   Haffner, Steven M ^c  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

CARDIOVASCULAR DISEASE; CLUSTER ANALYSIS; DYSLIPIDEMIA; GENETIC EPIDEMIOLOGY; HYPERTENSION; INSULIN RESISTANCE; METABOLIC DISORDER; MULTIPLE METABOLIC SYNDROME; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; REVIEW;

EID: 0032442860     PISSN: 0193936X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.epirev.a017978     Document Type: Review

References (209)

1. Jousilahti P, Tuomilehto J, Korhonen HJ, et al. Trends in cardiovascular disease risk factor clustering in eastern Finland: results of 15-year follow-up of the North Karelia Project. Prev Med 1994;23:6-14.
2. Assmann G, Schulte H. The Prospective Cardiovascular Münster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease. Am Heart J 1988;116: 1713-24.
3. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-94.
4. Després JP. The insulin resistance-dyslipidemia syndrome: the most prevalent cause of coronary artery disease? Can Med Assoc J 1993;148:1339-40.
5. Ferrannini E. Syndrome X. Horm Res 1993;39(Suppl 3): 107-11.
6. Haffner SM, Valdez RA, Hazuda HP, et al. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes 1992;41:715-22.
7. Hanefeld M, Leonhardt W. Das metabolische Syndrom. Dtsch Gesundh. Wesen 1981;36:545-51.
8. Hjermann I. The metabolic cardiovascular syndrome: syndrome X, Reaven's syndrome, insulin resistance syndrome, atherothrombogenic syndrome. J Cardiovasc Pharmacol 1992;20(Suppl 8):S5-10.
9. Kaplan NM. The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989;149:1514-20.
10. Kesäniemi YA, Lilja M, Kervinen K, et al. Multiple metabolic syndrome: aspects of genetic epidemiology and molecular genetics. Ann Med 1992;24:461-4.
11. Os I, Nordby G. Hypertension and the metabolic cardiovascular syndrome: special reference to premenopausal women. J Cardiovasc Pharmacol 1992;20(Suppl 8):S15-21.
12. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
13. Zimmet PZ, Collins VR, Dowse GK, et al. Is hyperinsulinaemia a central characteristic of a chronic cardiovascular risk factor clustering syndrome? Mixed findings in Asian Indian, Creole and Chinese Mauritians. Diabet Med 1994; 11:388-96.
14. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities - the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996; 334:374-81.
15. Stedman's medical dictionary. 25th ed. Baltimore, MD: Williams and Wilkins, 1990.
16. Mayer EJ, Newman B, Austin MA, et al. Genetic and environmental influences on insulin levels and the insulin resistance syndrome: an analysis of women twins. Am J Epidemiol 1996;143:323-32.
17. Mitchell BD, Haffner SM, Hazuda HP, et al. The relation between serum insulin levels and 8-year changes in lipid, lipoprotein, and blood pressure levels. Am J Epidemiol 1992; 136:12-22.
18. Chan JCN, Cheung JCK, Lau EMC, et al. The metabolic syndrome in Hong Kong Chinese: the interrelationships among its components analyzed by structural equation modeling. Diabetes Care 1996;19:953-9.
19. Mitchell BD, Kammerer CM, Mahaney MC, et al. Genetic analysis of the IRS: pleiotropic effects of genes influencing insulin levels on lipoprotein and obesity measures. Arterioscler Thromb Vase Biol 1996;16:281-8.
20. Hong Y, Pedersen NL, Brismar K, et al. Genetic and environmental architecture of the features of the insulin-resistance syndrome. Am J Hum Genet 1997;60:143-52.
21. Carmelli D, Cardon LR, Fabsitz R. Clustering of hypertension, diabetes, and obesity in adult male twins: same genes or same environments? Am J Hum Genet 1994;55:566-73.
22. Liese AD, Mayer-Davis EJ, Tyroler HA, et al. Development of the multiple metabolic syndrome in the ARIC cohort: joint contribution of insulin, BMI, and WHR. Ann Epidemiol 1997;7:407-16.
23. Ferrannini E, Haffner SM, Mitchell BD, et al. Hyper-insulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991;34:416-22.
24. Haffner SM, Mykkänen L, Valdez RA, et al. Evaluation of two insulin assays in insulin resistance syndrome (syndrome X). Arterioscler Thromb 1994;14:1430-7.
25. Schmidt MI, Watson RL, Duncan BB, et al. Clustering of dyslipidemia, hyperuricemia, diabetes, and hypertension and its association with fasting insulin and central and overall obesity in a general population. Metabolism 1996;45: 699-706.
26. Selby JV, Austin MA, Newman B, et al. LDL subclass phenotypes and the insulin resistance syndrome in women. Circulation 1993;88:381-7.
27. Juhan-Vague I, Thompson SG, Jespersen J, et al. Involvement of the hemostatic system in the insulin resistance syndrome: a study of 1500 patients with angina pectoris. ECAT Angina Pectoris Study Group. Arterioscler Thromb 1993;13:1865-73.
28. Knudsen P, Eriksson J, Lahdenperä S, et al. Changes of lipolytic enzymes cluster with insulin resistance syndrome. Botnia Study Group. Diabetologia 1995;38:344-50.
29. Ferrannini E, Baldi S, Stern M. Circulating free fatty acids are an integral part of the insulin resistance syndrome. (Abstract). Diabetes 1995;44:182A.
30. Kario K, Nago N, Kayaba K, et al. Characteristics of the insulin resistance syndrome in a Japanese population. The Jichi Medical School Cohort Study. Arterioscler Thromb Vase Biol 1996;16:269-74.
31. Edwards KL, Austin MA, Newman B, et al. Multivariate analysis of the insulin resistance syndrome in women. Arterioscler Thromb 1994;14:1940-5.
32. Criqui MH, Barrett-Connor E, Holdbrook MJ, et al. Clustering of cardiovascular disease risk factors. Prev Med 1980;9: 525-33.
33. Turner RC, Stratton IM, Matthews DR. Of insulin resistance and normalcy. Diabetologia 1992;35:696-8.
34. Schmidt MI, Duncan BB, Watson RL, et al. A metabolic syndrome in whites and African-Americans. The Atherosclerosis Risk in Communities baseline study. Diabetes Care 1996;19:414-18.
35. Criqui MH, Cowan LD, Heiss G, et al. Frequency and clustering of nonlipid coronary risk factors in dyslipoproteinemia. The Lipid Research Clinics Program Prevalence Study. Circulation 1986;73:I-40-50.
36. Eriksson H, Welin L, Wilhelmsen L, et al. Metabolic disturbances in hypertension: results from the population study 'men born in 1913'. J Intern Med 1992;232:389-95.
37. Wingard DL, Barrett-Connor E, Criqui MH, et al. Clustering of heart disease risk factors in diabetic compared to nondiabetic adults. Am J Epidemiol 1983;117:19-26.
38. Wingard DL, Barrett-Connor EL, Ferrara A, et al. Prevalence of insulin resistance syndrome among older adults without diabetes: a community-based study. (Abstract). Diabetes 1995;44:183A.
39. Raitakari OT, Porkka KVK, Räsänen L, et al. Clustering and six year cluster-tracking of serum total cholesterol, HDL-cholesterol and diastolic blood pressure in children and young adults. The Cardiovascular Risk in Young Finns Study. J Clin Epidemiol 1994;47:1085-93.
40. Bao W, Srinivasan SR, Berenson GS. Persistence of multiple cardiovascular risk clustering related to syndrome X from childhood to young adulthood. The Bogalusa Heart Study. (Abstract). Circulation 1994;90:I-25.
41. Mykkänen L, Haffner SM, Rönnemaa T, et al. Low insulin sensitivity is associated with clustering of cardiovascular disease risk factors. Am J Epidemiol 1997;146:315-21.
42. Vague J. The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr 1956;4:20-34.
43. Després JP. Abdominal obesity as important component of insulin-resistance syndrome. Nutrition 1993;9:452-9.
44. Kissebah AH, Peiris AN, Evans DJ. Mechanisms associating body fat distribution to glucose intolerance and diabetes mellitus: window with a view. Acta Med Scand Suppl 1988; 723:79-89.
45. Selby JV, Newman B, Quiroga J, et al. Concordance for dyslipidemic hypertension in male twins. JAMA 1991;265: 2079-84.
46. Knowler WC, Petlitt DJ, Savage PJ, et al. Diabetes incidence in Pima Indians: contributions of obesity and parental diabetes. Am J Epidemiol 1981;113:144-56.
47. Harris MI, Hadden WC, Knowler WC, et al. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population aged 20-74 yr. Diabetes 1987;36: 523-34.
48. Cooper R, David R. The biological concept of race and its application to public health and epidemiology. J Health Polit Policy Law 1986;11:97-116.
49. Krieger N, Fee E. Man-made medicine and women's health: the biopolitics of sex/gender and race/ethnicity. Int J Health Serv 1994;24:265-83.
50. Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol 1993;137:959-65.
51. Swinburn BA, Nyomba BL, Saad MF, et al. Insulin resistance associated with lower rates of weight gain in Pima Indians. J Clin Invest 1991;88:168-73.
52. Hoag S, Marshall JA, Jones RH, et al. High fasting insulin levels associated with lower rates of weight gain in persons with normal glucose tolerance: The San Luis Valley Diabetes Study. Int J Obes Relat Metab Disord 1995;19:175-80.
53. Folsom AR, Vitelli LL, Lewis CE, et al. Is fasting insulin concentration inversely associated with rate of weight gain? Contrasting findings from the CARDIA and ARIC study cohorts. Int J Obes Relat Metab Disord 1998;22:48-54.
54. Odeleye OE, de Courten M, Pettitt DJ, et al. Fasting hyperinsulinemia is a predictor of increased body weight gain and obesity in Pima Indian children. Diabetes 1997;46:1341-5.
55. Bergman RN. Lilly lecture 1989. Toward physiological understanding of glucose tolerance: minimal-model approach. Diabetes 1989;38:1512-27.
56. Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocr Rev 1985;6:45-86.
57. Carson CA, Meilahn EN, Caggiula AW. Comparison of waist measurements: a methodologic issue in longitudinal studies. J Am Diet Assoc 1994;94:771-2.
58. van der Kooy K, Seidell JC. Techniques for the measurement of visceral fat: a practical guide. Int J Obes Relat Metab Disord 1993;17:187-96.
59. Zamboni M, Armellini F, Milani MP, et al. Evaluation of regional body fat distribution: comparison between W/H ratio and computed tomography in obese women. J Intern Med 1992;232:341-7.
60. Smalley KJ, Knerr AN, Kendrick ZV, et al. Reassessment of body mass indices. Am J Clin Nutr 1990;52:405-8.
61. Ross R, Shaw KD, Rissanen J, et al. Sex differences in lean and adipose tissue distribution by magnetic resonance imaging: anthropometric relationships. Am J Clin Nutr 1994; 59:1277-85.
62. Kvist H, Chowdhury B, Grangård U, et al. Total and visceral adipose-tissue volumes derived from measurements with computed tomography in adult men and women: predictive equations. Am J Clin Nutr 1988;48:1351-61.
63. Marks GC, Habicht JP, Mueller WH. Reliability, dependability, and precision of anthropometric measurements. The Second National Health and Nutrition Examination Survey 1976-1980. Am J Epidemiol 1989;130:578-87.
64. Mueller WH, Malina RM. Relative reliability of circumferences and skinfolds as measures of body fat distribution. Am J Phys Anthropol 1987;72:437-9.
65. Manolio TA, Savage PJ, Burke GL, et al. Association of fasting insulin with blood pressure and lipids in young adults. The CARDIA study. Arteriosclerosis 1990;10:430-6.
66. Karter AJ, Mayer-Davis EJ, Selby JV, et al. Insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women. The Insulin Resistance and Atherosclerosis Study. Diabetes 1996;45:1547-55.
67. Haffner SM, Howard G, Mayer E, et al. Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM. The Insulin Resistance Atherosclerosis Study. Diabetes 1997;46:63-9.
68. Donahue RP, Prineas RJ, DeCarlo-Donahue R, et al. The female 'insulin advantage' in a biracial cohort: results from the Miami Community Health Study. Int J Obes Relat Metab Disord 1996;20:76-82.
69. Dowling HJ, Pi-Sunyer FX. Race-dependent health risks of upper body obesity. Diabetes 1993;42:537-43.
70. Haffner SM, D'Agostino R, Saad MF, et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes 1996;45:742-8.
71. Ferrara A, Barrett-Connor E, Wingard DL, et al. Sex differences in insulin levels in older adults and the effect of body size, estrogen replacement therapy, and glucose tolerance status. The Rancho Bernardo Study, 1984-1987. Diabetes Care 1995;18:220-5.
72. Nabulsi AA, Folsom AR, Heiss G, et al. Fasting hyperinsulinemia and cardiovascular disease risk factors in nondiabetic adults: stronger associations in lean versus obese subjects. Metabolism 1995;44:914-22.
73. Bogardus C. Insulin resistance in the pathogenesis of NIDDM in Pima Indians. Diabetes Care 1993;16:228-31.
74. Olefsky JM. Insulin resistance and the pathogenesis of non-insulin dependent diabetes mellitus: cellular and molecular mechanisms. In: Östenson CG, Efendic S, Vranic M, eds. New concepts in the pathogenesis of NIDDM. New York, NY: Plenum Press, 1993:129-50.
75. Taylor SI, Accili D, Imai Y. Insulin resistance or insulin deficiency: which is the primary cause of NIDDM? Diabetes 1994;43:735-40.
76. Burchfiel CM, Curb JD, Rodriguez BL, et al. Incidence and predictors of diabetes in Japanese-American men. The Honolulu Heart Program. Ann Epidemiol 1995;5:33-43.
77. Cassano PA, Rosner B, Vokonas PS, et al. Obesity and body fat distribution in relation to the incidence of non-insulin-dependent diabetes mellitus: a prospective cohort study of men in the Normative Aging Study. Am J Epidemiol 1992; 136:1474-86.
78. Feskens EJM, Kromhout D. Cardiovascular risk factors and the 25-year incidence of diabetes mellitus in middle-aged men. The Zutphen Study. Am J Epidemiol 1989;130:1101-8.
79. Haffner SM, Stern MP, Mitchell BD, et al. Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution. Diabetes 1990;39:283-8.
80. Hanson RL, Narayan KMV, McCance DR, et al. Rate of weight gain, weight fluctuation, and incidence of NIDDM. Diabetes 1995;44:261-6.
81. Lee ET, Anderson PS Jr, Bryan J, et al. Diabetes, parental diabetes, and obesity in Oklahoma Indians. Diabetes Care 1985;8:107-13.
82. Ohlson LO, Larsson B, Svärdsudd K, et al. The influence of body fat distribution on the incidence of diabetes mellitus: 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes 1985;34:1055-8.
83. Haffner SM, Miettinen H, Gaskill SP, et al. Decreased insulin action and insulin secretion predict the development of impaired glucose tolerance. Diabetologia 1996;39:1201-7.
84. Knowler WC, Pettitt DJ, Saad MF, et al. Diabetes mellitus in the Pima Indians: incidence, risk factors and pathogenesis. Diabetes Metab Rev 1990;6:1-27.
85. Charles MA, Fontbonne A, Thibult N, et al. Risk factors for NIDDM in white population. Paris Prospective Study. Diabetes 1991;40:796-9.
86. Banerji MA, Lebovitz HE. Insulin-sensitive and insulin-resistant variants in NIDDM. Diabetes 1989;38:784-92.
87. Pi-Sunyer FX. Obesity and diabetes in blacks. Diabetes Care 1990;13:1144-9.
88. Knowler WC, Pettitt DJ, Saad MF, et al. Obesity in the Pima Indians: its magnitude and relationship with diabetes. Am J Clin Nutr 1991;53(suppl):1543S-51S.
89. Brancati F, Mead L, Thomas J, et al. A prospective study of incident diabetes in black and white men: the Meharry-Hopkins Study. (Abstract). Diabetes 1995;44:6A.
90. Howard BV, Schneiderrnan N, Falkner B, et al. Insulin, health behaviors, and lipid metabolism. Metabolism 1993; 42:25-35.
91. Cambien F, Warnet JM, Eschwege E, et al. Body mass, blood pressure, glucose, and lipids: does plasma insulin explain their relationships? Arteriosclerosis 1987;7:197-202.
92. Donahue RP, Orchard TJ, Becker DJ, et al. Sex differences in the coronary heart disease risk profile: a possible role for insulin. The Beaver County Study. Am J Epidemiol 1987; 125:650-7.
93. Modan M, Halkin H, Lusky A, et al. Hyperinsulinemia is characterized by jointly disturbed plasma VLDL, LDL, and HDL levels: a population-based study. Arteriosclerosis 1988; 8:227-36.
94. Cigolini M, Seidell JC, Targher G, et al. Fasting serum insulin in relation to components of the metabolic syndrome in European healthy men: The European Fat Distribution Study. Metabolism 1995;44:35-40.
95. Cigolini M, Seidell JC, Charzewska J, et al. Fasting serum insulin in relation to fat distribution, serum lipid profile, and blood pressure in European women. The European Fat Distribution Study. Metabolism 1991;40:781-7.
96. Wing RR, Bunker CH, Kuller LH, et al. Insulin, body mass index, and cardiovascular risk factors in premenopausal women. Arteriosclerosis 1989;9:479-84.
97. Haffner SM, Fong D, Hazuda HP, et al. Hyperinsulinemia, upper body adiposity, and cardiovascular risk factors in non-diabetics. Metabolism 1988;37:338-45.
98. Mykkänen L, Haffner SM, Rönnemaa T, et al. Is there a sex difference in the association of plasma insulin level and insulin sensitivity with serum lipids and lipoproteins? Metabolism 1994;43:523-8.
99. Laakso M, Sarlund H, Mykkänen L. Insulin resistance is associated with lipid and lipoprotein abnormalities in subjects with varying degrees of glucose tolerance. Arteriosclerosis 1990;10:223-31.
100. Mykkänen L, Kuusisto J, Haffner SM, et al. Hyperinsulinemia predicts multiple atherogenic changes in lipoproteins in elderly subjects. Arterioscler Thromb 1994;14:518-26.
101. Howard BV. Insulin, insulin resistance, and dyslipidemia. Ann N Y Acad Sci 1993;683:1-8.
102. Reaven GM. Role of insulin resistance in human disease (syndrome X): an expanded definition. Annu Rev Med 1993; 44:121-31.
103. Björntorp P. "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 1990;10:493-6.
104. Després JP, Marette A. Relation of components of insulin resistance syndrome to coronary disease risk. Curr Opin Lipidol 1994;5:274-89.
105. Reaven GM, Chen YDI. Role of insulin in regulation of lipoprotein metabolism in diabetes. Diabetes Metab Rev 1988;4:639-52.
106. Haffner SM, Mykkänen L, Robbins D, et al. A preponderance of small dense LDL is associated with specific insulin, proinsulin and the components of the insulin resistance syndrome in non-diabetic subjects. Diabetologia 1995;38:1328-36.
107. Austin MA, Breslow JL, Hennekens CH, et al. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA 1988;260:1917-21.
108. Katzel LI, Krauss RM, Goldberg AP. Relations of plasma TG and HDL-C concentrations to body composition and plasma insulin levels are altered in men with small LDL particles. Arterioscler Thromb 1994;14:1121-8.
109. Austin MA, Brunzell JD, Fitch WL, et al. Inheritance of low density lipoprotein subclass patterns in familial combined hyperlipidemia. Arteriosclerosis 1990;10:520-30.
110. Barakat HA, Carpenter JW, McLendon VD, et al. Influence of obesity, impaired glucose tolerance, and NIDDM on LDL structure and composition: possible link between hyperinsulinemia and atherosclerosis. Diabetes 1990;39:1527-33.
111. Reaven GM, Chen YDI, Jeppesen J, et al. Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles. J Clin Invest 1993;92:141-6.
112. Haffner SM, Mykkänen L, Stern MP, et al. Greater effect of diabetes on LDL size in women than in men. Diabetes Care 1994;17:1164-71.
113. Austin MA, Mykkänen L, Kuusisto J, et al. Prospective study of small LDLs as a risk factor for non-insulin dependent diabetes mellitus in elderly men and women. Circulation 1995;92:1770-8.
114. Cassano PA, Segal MR, Vokonas PS, et al. Body fat distribution, blood pressure, and hypertension: a prospective cohort study of men in the Normative Aging Study. Ann Epidemiol 1990;1:33-48.
115. Leitschuh M, Cupples LA, Kannel W, et al. High-normal blood pressure progression to hypertension in the Framingham Heart Study. Hypertension 1991;17:22-7.
116. Neser WB, Thomas J, Semenya K, et al. Obesity and hypertension in a longitudinal study of black physicians: The Meharry Cohort Study. J Chronic Dis 1986;39:105-13.
117. Donahue RP, Skyler JS, Schneiderman N, et al. Hyperinsulinemia and elevated blood pressure: cause, confounder, or coincidence? Am J Epidemiol 1990;132:827-36.
118. Feskens EJM, Tuomilehto J, Stengård JH, et al. Hypertension and overweight associated with hyperinsulinaemia and glucose tolerance: a longitudinal study of the Finnish and Dutch cohorts of the Seven Countries Study. Diabetologia 1995;38: 839-47.
119. Hall JE. Hyperinsulinemia: a link between obesity and hypertension? Kidney Int 1993;43:1402-17.
120. Mykkänen L, Kuusisto J, Haffner S, et al. Fasting plasma insulin in relation to the development of hypertension in elderly subjects. (Abstract). Circulation 1994;90:I-665.
121. Pyörälä K, Savolainen E, Kaukola S, et al. Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9 1/2-year follow-up of the Helsinki Policemen Study population. Acta Med Scand Suppl 1985;701:38-52.
122. Lind L, Lithell H. Decreased peripheral blood flow in the pathogenesis of the metabolic syndrome comprising hypertension, hyperlipidemia, and hyperinsulinemia. Am Heart J 1993;125:1494-7.
123. Esparrago J, Raffel L, Cantor R, et al. Insulin sensitivity and salt sensitivity are interrelated and genetically influenced in Mexican American families with hypertension. (Abstract). Diabetes 1995;44:125A.
124. Haffner SM. Epidemiology of hypertension and insulin resistance syndrome. J Hypertens 1997;15(Suppl 1):S25-30.
125. Asch S, Wingard DL, Barrett-Connor EL. Are insulin and hypertension independently related? Ann Epidemiol 1991;1: 231-44.
126. Saad MF, Lillioja S, Nyomba BL, et al. Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med 1991;324:733-9.
127. Lissner L, Bengtsson C, Lapidus L, et al. Fasting insulin in relation to subsequent blood pressure changes and hypertension in women. Hypertension 1992;20:797-801.
128. Salonen JT, Lakka TA, Lakka HM, et al. Hyperinsulinemia is associated with the incidence of hypertension and dyslipidemia in middle-aged men. Diabetes 1998;47:270-5.
129. Fagot-Campagna A, Balkau B, Simon D, et al. Is insulin an independent risk factor for hypertension? The Paris Prospective Study. Int J Epidemiol 1997;26:542-50.
130. Shetterly SM, Rewers M, Hamman RF, et al. Patterns and predictors of hypertension incidence among Hispanics and non-Hispanic whites. The San Luis Valley Diabetes Study. J Hypertens 1994;12:1095-102.
131. Liese AD, Mayer EJ, Brancati FL, et al. Elevated fasting insulin predicts incident hypertension in the Atherosclerosis Risk in Communities Study. (Abstract). Circulation 1996;94: I-214.
132. Ferrara A, Barrett-Connor EL, Edelstein SL. Hyperinsulinemia does not increase the risk of fatal cardiovascular disease in elderly men or women without diabetes. The Rancho Bernardo Study, 1984-1991. Am J Epidemiol 1994; 140:857-69.
133. McKeigue P, Davey G. Associations between insulin levels and cardiovascular disease are confounded by comorbidity. Diabetes Care 1995;18:1294-8.
134. Fontbonne A, Charles MA, Thibult N, et al. Hyperinsulinaemia as a predictor of coronary heart disease mortality in a healthy population. The Paris Prospective Study, 15-year follow-up. Diabetologia 1991;34:356-61.
135. Casassus P, Fontbonne A, Thibult N, et al. Upper-body fat distribution: a hyperinsulinemia-independent predictor of coronary heart disease mortality. The Paris Prospective Study. Arterioscler Thromb 1992;12:1387-92.
136. Perry IJ, Wannamethee SG, Whincup PH, et al. Serum insulin and incident coronary heart disease in middle-aged British men. Am J Epidemiol 1996;144:224-34.
137. Després JP, Lamarche B, Mauriège P, et al. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996;334:952-7.
138. Tuomilehto J, Tamosiunas A, Dowse G, et al. Hyperinsulinemia does not explain the high risk of cardiovascular disease (CVD) in Mauritius. (Abstract). Diabetologia 1996;39:A68.
139. Folsom AR, Szklo M, Stevens J, et al. A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes. The Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care 1997;20:935-42.
140. Welborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care 1979;2: 154-60.
141. Howard G, O'Leary DH, Zaccaro D, et al. Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation 1996;93:1809-17.
142. Freedman DS, Williamson DF, Croft JB, et al. Relation of body fat distribution to ischemic heart disease. The National Health and Nutrition Examination Survey I (NHANES I) Epidemiologic Follow-up Study. Am J Epidemiol 1995;142: 53-63.
143. Larsson B, Svärdsudd K, Welin L, et al. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J (Clin Res Ed) 1984;288: 1401-4.
144. Manson JE, Willett WC, Stampfer MJ, et al. Body weight and mortality among women. N Engl J Med 1995;333: 677-85.
145. Willett WC, Manson JE, Stampfer MJ, et al. Weight, weight change, and coronary heart disease in women: risk within the 'normal' weight range. JAMA 1995;273:461-5.
146. Stevens J, Keil JE, Rust PF, et al. Body mass index and body girths as predictors of mortality in black and white women. Arch Intern Med 1992;152:1257-62.
147. Stevens J, Keil JE, Rust PF, et al. Body mass index and body girths as predictors of mortality in black and white men. Am J Epidemiol 1992;135:1137-46.
148. Zimmet PZ. Hyperinsulinemia - how innocent a bystander? Diabetes Care 1993;16(Suppl 3):56-70.
149. Reaven GM, Chen YDI. Insulin resistance, its consequences, and coronary heart disease: must we choose one culprit? Circulation 1996;93:1780-3.
150. Jarrett RJ. Is insulin atherogenic? Diabetologia 1988;31: 71-5.
151. Fontbonne A. Insulin: a sex hormone for cardiovascular risk? Circulation 1991;84:1442-4.
152. Nelson RG, Sievers ML, Knowler WC, et al. Low incidence of fatal coronary heart disease in Pima Indians despite high prevalence of non-insulin-dependent diabetes. Circulation 1990;81:987-95.
153. Khoury MJ, Beaty TH, Cohen BH. Fundamentals of genetic epidemiology. New York, NY: Oxford University Press, 1993.
154. Martin BC, Warram JH, Rosner B, et al. Familial clustering of insulin sensitivity. Diabetes 1992;41:850-4.
155. Bogardus C, Lillioja S, Nyomba BL, et al. Distribution of in vivo insulin action in Pima Indians as mixture of three normal distributions. Diabetes 1989;38:1423-32.
156. Schumacher MC, Hasstedt SJ, Hunt SC, et al. Major gene effect for insulin levels in familial NIDDM pedigrees. Diabetes 1992;41:416-23.
157. Austin MA, King MC, Bawol RD, et al. Risk factors for coronary heart disease in adult female twins: genetic heritability and shared environmental influences. Am J Epidemiol 1987;125:308-18.
158. Després JP, Moorjani S, Lupien PJ, et al. Genetic aspects of susceptibility to obesity and related dyslipidemias. Mol Cell Biochem 1992;113:151-69.
159. Fabsitz RR, Sholinsky P, Carmelli D. Genetic influences on adult weight gain and maximum body mass index in male twins. Am J Epidemiol 1994;140:711-20.
160. Austin MA, Friedlander Y, Newman B, et al. Genetic influences on changes in body mass index: a longitudinal analysis of women twins. Obes Res 1997;5:326-31.
161. Newman B, Selby JV, Quesenberry CP Jr, et al. Nongenetic influences of obesity on other cardiovascular disease risk factors: an analysis of identical twins. Am J Public Health 1990;80:675-8.
162. Haffner SM, Stern MP, Hazuda HP, et al. Increased insulin concentrations in nondiabetic offspring of diabetic parents. N Engl J Med 1988;319:1297-301.
163. Leslie RDG, Volkmann HP, Poncher M, et al. Metabolic abnormalities in children of non-insulin dependent diabetics. Br Med J (Clin Res Ed) 1986;293:840-2.
164. Wing RR, Matthews KA, Kuller LH, et al. Environmental and familial contributions to insulin levels and change in insulin levels in middle-aged women. JAMA 1992;268: 1890-5.
165. Laws A, Stefanick ML, Reaven GM. Insulin resistance and hypertriglyceridemia in nondiabetic relatives of patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1989;69:343-7.
166. Gulli G, Ferrannini E, Stern M, et al. The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents. Diabetes 1992; 41:1575-86.
167. Eriksson J, Franssila-Kallunki A, Ekstrand A, et al. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med 1989;321: 337-43.
168. Lapidus L, Bengtsson C, Lissner L, et al. Family history of diabetes in relation to different types of obesity and change of obesity during 12-yr period: results from prospective population study of women in Göteborg, Sweden. Diabetes Care 1992;15:1455-8.
169. Mayer EJ, Newman B, Quesenberry CP Jr, et al. Usual dietary fat intake and insulin concentrations in healthy women twins. Diabetes Care 1993;16:1459-69.
170. Regensteiner JG, Mayer EJ, Shetterly SM, et al. Relationship between habitual physical activity and insulin levels among nondiabetic men and women. San Luis Valley Diabetes Study. Diabetes Care 1991;14:1066-74.
171. Mayer-Davis EJ, D'Agostino R, Jr., Karter AJ, et al. Intensity and amount of physical activity in relation to insulin sensitivity. The Insulin Resistance Atherosclerosis Study. JAMA 1998;279:669-74.
172. Mayer EJ, Newman B, Quesenberry CP Jr, et al. Alcohol consumption and insulin concentrations: role of insulin in associations of alcohol intake with high-density lipoprotein cholesterol and triglycerides. Circulation 1993;88:2190-7.
173. Barnard RJ, Ugianskis EJ, Martin DA, et al. Role of diet and exercise in the management of hyperinsulinemia and associated atherosclerotic risk factors. Am J Cardiol 1992;69: 440-4.
174. Facchini FS, Hollenbeck CB, Jeppesen J, et al. Insulin resistance and cigarette smoking. Lancet 1992;339:1128-30.
175. Smith U. Smoking elicits the insulin resistance syndrome: new aspects of the harmful effect of smoking. J Intern Med 1995;237:435-7.
176. Ghosh S, Schork NJ. Genetic analysis of NIDDM: the study of quantitative traits. Diabetes 1996;45:1-14.
177. Hanis CL, Boerwinkle E, Chakraborty R, et al. A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet 1996;13:161-6.
178. Kaprio J, Tuomilehto J, Koskenvuo M, et al. Concordance for type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus in a population-based cohort of twins in Finland. Diabetologia 1992;35:1060-7.
179. Newman B, Selby JV, King MC, et al. Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia 1987;30:763-8.
180. Østbye T, Welby TJ, Prior IAM, et al. Type 2 (non-insulin-dependent) diabetes mellitus, migration and westernisation. The Tokelau Island Migrant Study. Diabetologia 1989;32: 585-90.
181. Monterrosa AE, Haffner SM, Stern MP, et al. Sex difference in lifestyle factors predictive of diabetes in Mexican-Americans. Diabetes Care 1995;18:448-56.
182. Schmidt MI, Duncan BB, Canani LH, et al. Association of waist-hip ratio with diabetes mellitus: strength and possible modifiers. Diabetes Care 1992;15:912-14.
183. Feinleib M, Garrison RJ, Fabsitz R, et al. The NHLBI twin study of cardiovascular disease risk factors: methodology and summary of results. Am J Epidemiol 1977;106:284-95.
184. Morrison JA, Namboodiri K, Green P, et al. Familial aggregation of lipids and lipoproteins and early identification of dyslipoproteinemia. The Collaborative Lipid Research Clinics Family Study. JAMA 1983;250:1860-8.
185. Austin MA, Newman B, Selby JV, et al. Genetics of LDL subclass phenotypes in women twins: concordance, heritability, and commingling analysis. Arterioscler Thromb 1993; 13:687-95.
186. Annest JL, Sing CF, Biron P, et al. Familial aggregation of blood pressure and weight in adoptive families. II. Estimation of the relative contributions of genetic and common environmental factors to blood pressure correlations between family members. Am J Epidemiol 1979;110:492-503.
187. Clarke WR, Schrott HG, Burns TL, et al. Aggregation of blood pressure in the families of children with labile high systolic blood pressure. The Muscatine Study. Am J Epidemiol 1986;123:67-80.
188. Shear CL, Webber LS, Freedman DS, et al. The relationship between
189. Williams RR, Hunt SC, Hopkins PN, et al. Tabulations and expectations regarding the genetics of human hypertension. Kidney Int 1994;45(Suppl 44):S57-64.
190. Brunzell JD, Schrott HG, Motulsky AG, et al. Myocardial infarction in the familial forms of hypertriglyceridemia. Metabolism 1976;25:313-20.
191. Goldstein JL, Hazzard WR, Schrott HG, et al. Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction. J Clin Invest 1973;52:1533-43.
192. Williams RR, Hopkins PN, Hunt SC, et al. Familial dyslipidaemic hypertension and other multiple metabolic syndromes. Ann Med 1992;24:469-75.
193. Edwards KL, Newman B, Mayer E, et al. Heritability of factors of the insulin resistance syndrome in women twins. Genet Epidemiol 1997;14:241-53.
194. Burke GL, Savage PJ, Sprafka JM, et al. Relation of risk factor levels in young adulthood to parental history of disease. The CARDIA study. Circulation 1991;84:1176-87.
195. Ekoé JM, Thomas F, Balkau B, et al. Effect of maternal diabetes on the pattern of selected insulin resistance syndrome parameters in normal glucose tolerant subjects of two Algonquin Indian communities in Quebec. Diabetes Care 1996;19:822-6.
196. Liese AD, Mayer-Davis EJ, Tyroler HA, et al. Familial components of the multiple metabolic syndrome. The ARIC study. Diabetologia 1997;40:963-70.
197. Mykkänen L, Kuusisto J, Pyörälä K, et al. Cardiovascular disease risk factors as predictors of type 2 (non-insulin-dependent) diabetes mellitus in elderly subjects. Diabetologia 1993;36:553-9.
198. Haffner SM, Valdez R, Morales PA, et al. Greater effect of glycemia on incidence of hypertension in women than in men. Diabetes Care 1992;15:1277-84.
199. Kristiansson K, Sigfusson N, Sigvaldason H, et al. Glucose tolerance and blood pressure in a population-based cohort study of males and females. The Reykjavik Study. J Hypertens 1995;13:581-6.
200. Morales PA, Mitchell BD, Valdez RA, et al. Incidence of NIDDM and impaired glucose tolerance in hypertensive subjects. The San Antonio Heart Study. Diabetes 1993;42:154-61.
201. Salomaa VV, Strandberg TE, Vanhanen H, et al. Glucose tolerance and blood pressure: long term follow up in middle aged men. BMJ 1991;302:493-6.
202. Stern MP, Morales PA, Valdez RA, et al. Predicting diabetes: moving beyond impaired glucose tolerance. Diabetes 1993; 42:706-14.
203. Vaccaro O, Imperatore G, Iovino V, et al. Does impaired glucose tolerance predict hypertension? A prospective analysis. Diabetologia 1996;39:70-6.
204. Shetterly SM, Rewers M, Hamman RF. Does hypertension precede glucose intolerance in the insulin resistance syndrome? The San Luis Valley Diabetes Study. (Abstract). Am J Epidemiol 1993;138:611-12.
205. Levy D, Kannel WB. Cardiovascular risks: new insights from Framingham. Am Heart J 1988;116:266-72.
206. Kuczmarski RJ, Flegal KM, Campbell SM, et al. Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA 1994;272:205-11.
207. Carroll M, Sempos C, Briefel R, et al. Serum lipids of adults 20-74 years: United States, 1976-80. Vital Health Stat 11 1993;242:1-107.
208. Pietinen P, Vartiainen E, Männistö S. Trends in body mass index and obesity among adults in Finland from 1972 to 1992. Int J Obes Relat Metab Disord 1996;20:114-20.
209. Prentice AM, Jebb SA. Obesity in Britain: gluttony or sloth? BMJ 1995;311:437-9.